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Modification of the cytidine in the first anticodon position of the
AUA decoding tRNAIle (tRNAIle2 ) of bacteria and archaea is essential
for this tRNA to read the isoleucine codon AUA and to differentiate
between AUA and the methionine codon AUG. To identify the
modified cytidine in archaea, we have purified this tRNA species
from Haloarcula marismortui, established its codon reading proper-
ties, used liquid chromatography–mass spectrometry (LC-MS) to
map RNase A and T1 digestion products onto the tRNA, and used
LC-MS/MS to sequence the oligonucleotides in RNase A digests.
These analyses revealed that the modification of cytidine in the an-
ticodon of tRNAIle2 adds 112 mass units to its molecular mass and
makes the glycosidic bond unusually labile during mass spectral
analyses. Accurate mass LC-MS and LC-MS/MS analysis of total
nucleoside digests of the tRNAIle2 demonstrated the absence in
the modified cytidine of the C2-oxo group and its replacement
by agmatine (decarboxy-arginine) through a secondary amine
linkage. We propose the name agmatidine, abbreviation Cþ, for
this modified cytidine. Agmatidine is also present in Methanococ-
cus maripaludis tRNAIle2 and in Sulfolobus solfataricus total tRNA,
indicating its probable occurrence in the AUA decoding tRNAIle
of euryarchaea and crenarchaea. The identification of agmatidine
shows that bacteria and archaea have developed very similar stra-
tegies for reading the isoleucine codon AUA while discriminating
against the methionine codon AUG.
agmatine ∣ decoding ∣ RNA modification ∣ tRNA ∣ wobble pairing
The genetic code table consists of sixteen four-codon boxes.In fourteen of the boxes, all four codons either specify the
same amino acid or are split into two sets of two codons, with
each set encoding a different amino acid. For example, the
UUN box is split into UUU/UUC coding for phenylalanine
and UUA/UUG coding for leucine. The wobble hypothesis of
Crick proposes how a single phenylalanine tRNA with G in
the first anticodon position can base pair with either U or C
and a single leucine tRNA with a modified U (or 2-thioU) in
the anticodon can base pair with either A or G (1–3). The two
remaining boxes, UGN and AUN, are exceptions in that the
UGN box is split into UGU/UGC coding for cysteine, UGG
coding for tryptophan, and UGA being used as a stop codon,
whereas the AUN box is split into AUU/AUC/AUA coding for
isoleucine and AUG coding for methionine. The isoleucine co-
dons AUU and AUC can be read by an isoleucine tRNA with
G in the anticodon following the wobble pairing rules, but
how the AUA codon is read specifically by a tRNAIle without also
reading the AUG codon has been a question of much interest
over the years.
Different organisms have developed different strategies for
reading the AUA codon. Bacteria use a tRNAIle with the antic-
odon LAU (L ¼ lysidine) (4–7). Lysidine is a modified cytidine in
which the C2-oxo group of cytidine is replaced by lysine. Exactly
how it base pairs with A but not with G is not established.
Eukaryotes, on the other hand, contain a tRNAIle with the anti-
codon IAU (I ¼ inosine), which can read all three isoleucine co-
dons using the wobble pairing rules of Crick. They also contain a
tRNAIle with the anticodon ΨAΨ , which is thought to read only
the isoleucine codon AUA but not the methionine codon AUG
(8). Given these two distinct mechanisms in bacteria and
eukaryotes, a question of much interest is how the archaeal
tRNAIle accomplishes the task of reading the AUA codon.
In a recent paper, we showed that a tRNA with the anticodon
sequence CAU, which was annotated as a methionine tRNA in
the archaeonHaloarcula marismortui, was actually aminoacylated
with isoleucine in vivo (9). We showed that the cytidine in the
anticodon of this tRNA was modified, but not to lysidine as it
is in bacteria, and that the same modification was likely present
in other haloarchaea and in Methanocaldococcus jannaschii. We
also showed that modification of the cytidine was necessary for
aminoacylation of the tRNA with isoleucine in vitro. These find-
ings raised the question of the nature of the modification in the
archaeal AUA decoding tRNAIle (tRNAIle2 ) and its relationship,
if any, to lysidine in Escherichia coli tRNAIle2 .
Here, we describe the purification of two tRNAIle species from
H. marismortui. We show that tRNAIle1 binds to AUC but not to
AUA or AUG on the ribosome, whereas tRNAIle2 binds to AUA
but not to AUC, AUG, or AUU. Mass spectral analysis of nucleo-
sides and oligonucleotides isolated from tRNAIle2 show that the
modified cytidine is located in the anticodon wobble position,
lacks the C2-oxo group, and has instead agmatine (1-amino
4-guanidino butane) attached to it through a secondary amine
linkage. We propose the name agmatidine and the abbreviation
Cþ for this modified nucleoside. Agmatidine is also present in
tRNAIle2 from Methanococcus maripaludis and in total tRNA iso-
lated from Sulfolobus solfataricus, indicating its possible presence
in tRNAIle2 of euryarchaea and crenarchaea.
Agmatidine is in many ways similar to lysidine. In both cases
the C2-oxo group of cytidine is replaced by either of two closely
related basic amino acids, decarboxy-arginine or lysine. Thus,
bacteria and archaea have developed very similar strategies for
generating a tRNAIle2 to read the isoleucine codon AUA without
also reading the methionine codon AUG. The identification of
agmatidine also suggests that agmatine, which is a known
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neuromodulator (10, 11), and which is essential for polyamine
biosynthesis in the archaeon Thermococcus kodakaraensis (12),
may also be essential in euryarchaea and in crenarchaea (13)
for modification of the cytidine required for decoding the
AUA codon by tRNAIle2 .
Results
Purification and Characterization of Isoleucine tRNAs from H. maris-
mortui. Starting from total tRNA, a two-step procedure, involving
hybrid selection of tRNA with biotinylated DNA oligonucleo-
tides bound to streptavidin sepharose followed by native polya-
crylamide gel fractionation of the enriched tRNA, was used to
isolate pure tRNAIles. The biotinylated oligonucleotides were
complementary to nucleotides 54–73 of tRNAIle1 or tRNA
Ile
2
(Fig. 1A) and contained biotin at the 3′-hydroxyl end. The final
yields of purified tRNAs from approximately 1; 000 A260 units of
total tRNAwere 6–8 A260 units for tRNAIle1 and 0.6–0.8 A260 unit
for tRNAIle2 . The significantly lower yield of tRNA
Ile
2 compared to
tRNAIle1 reflects the low abundance of this tRNA and the fact
that AUA is a rarely used codon in haloarchaea as it is in E. coli
(14).
Fig. 1B shows that the purified tRNAs are essentially homo-
geneous. tRNAIle1 yielded only one band on a native polyacryla-
mide gel upon staining with ethidium bromide, and this band
hybridized to the corresponding complementary oligonucleotide
in Northern blots. tRNAIle2 yielded two bands, a strong band and a
weaker one, with both bands hybridizing to the oligonucleotide
complementary to this tRNA. Based on a comparison of inten-
sities of the hybridization bands and the amount of total tRNA
(0.5 A260 unit) and the purified tRNAs (0.005 A260 unit) loaded
on the gel, the purified tRNAIle1 is enriched approximately 57-fold
compared to total tRNA, and the purified tRNAIle2 is enriched
approximately 500-fold.
Additional evidence that the tRNAIle2 is essentially homoge-
neous was derived from gel electrophoretic analysis of partial
RNase T1 digests of 5′-32P-labeled tRNAIle2 (Fig. 1C). The
32P-la-
beled bands in the RNase T1 lane are due to cuts at G residues,
and these are consistent with the pattern expected for tRNAIle2 .
There is no band due to cleavage by RNase T1 at G26 because
G26 is dimethylated in the tRNA and it is known that under
conditions of partial RNase T1 digestion there is no cleavage
of the phosphodiester bond on the 3′-side of the dimethyl-G
residue (15).
The pattern obtained in partial alkali digests shows a pro-
nounced shift in gel electrophoretic mobility of the 5′-32P-labeled
oligonucleotide going from nucleotide 33 to 34. We had shown
previously that nucleotide 34 contained a modified cytidine
(9). The presence of nine bands between G31 and G41 in the
alkali digest shows that every phosphodiester bond between
G31 and G41 is cleaved by alkali. This means that none of the
nucleotides in between contain a substitution in the 2′-hydroxyl
group. Therefore, the very pronounced shift in the gel electro-
phoretic mobility indicates strongly that the modified cytidine
has at least one if not more positive charges in the ring, which
would retard the electrophoretic migration of the oligonucleotide
that contained the modified cytidine (16).
Codon Reading Properties of tRNAIle1 and tRNA
Ile
2 . Purified tRNAIle1
and tRNAIle2 were aminoacylated in vitro with
3H-Ile and the
3H-Ile-tRNAs were used for measuring oligonucleotide-directed
binding to H. marismortui ribosomes. The oligonucleotides used
as template had the following sequences AUGAUC, AUGAUA,
AUGAUG and AUGAUU. Results of ribosome binding
experiments show that tRNAIle1 binds to AUC but not to AUA
or AUG (Fig. 2A). In contrast, tRNAIle2 binds to AUA but not
to AUC, AUG (Fig. 2B), or to AUU (Table S1). Thus, the
modified cytidine in the anticodon wobble position of tRNAIle2
base pairs specifically with A but not with G, C, or U.
Localization of the Modified Cytidine (C*) in the Anticodon of tRNAIle2
and Determination of Its Mass. Liquid chromatography–mass
spectrometry (LC-MS)/MS RNase mapping and sequencing of
nucleic acids has been used extensively for the localization of
modified nucleosides in RNAs (17–21). Here, we used separate
digestions of tRNAIle2 with RNase T1 and RNase A combined
with bacterial alkaline phosphatase (BAP) followed by LC-MS/
MS to confirm C34 as the site of the unknown modification
and to identify the mass of the modified nucleoside. Knowledge
of the mass of the modified nucleoside was then used as a search
criterion for subsequent LC-MS and LC-MS/MS analysis of the
nucleosides present in a total digest of tRNAIle2 .
Digestion of tRNAIle2 with RNase T1 is predicted to yield
a decanucleotide 50-CUCAU½t6AACCGp-30, which would
Fig. 1. (A) Cloverleaf structure of tRNAIle2 from H. marismortui. Location of modified nucleosides is based on Gupta (46) and LC-MS analysis presented in this
work. Gþ (archaeosine); m22G (N
2, N2-dimethylguanosine); C* (modified cytidine); t6A (N6-threonylcarbamoyladenosine); m5C (5-methylcytidine); m1ψ
(1-methylpseudouridine); ψ (pseudouridine); Cm (2′-O-methylcytidine); m1I (1-methylinosine). (B) Purification of isoleucine tRNAs from H. marismortui. Native
PAGE analysis of total tRNA, purified tRNAIle2 (Ile2) and tRNA
Ile
1 (Ile1) is shown. tRNAs are visualized by ethidium bromide staining or Northern blot analysis using
probes specific for tRNAIle2 and tRNA
Ile
1 as indicated. (C) Characterization of purified tRNA
Ile
2 . The homogeneity of tRNA
Ile
2 was confirmed by partial RNase T1
digest (lane T1) of 5′-32P-labeled tRNA. 32P-labeled fragments were separated by denaturing PAGE and visualized by autoradiography; lane OH−, partial alkali
digest.








include C34 (designated as C*), the first nucleotide of the
anticodon. The predicted molecular mass of this digestion pro-
duct without the C34 modification is 3327.4 u. Consistent with
our previous results (9) showing that C34 is quantitatively
modified in tRNAIle2 , LC-MS analysis of the RNase T1 digestion
mixture failed to identify any m∕z values related to the above
unmodified sequence. Instead, abundant ions were detected
(Fig. S1) at m∕z 1718.8 (doubly charged) and m∕z 1145.5 (triply
charged). These m∕z values correspond to an oligonucleotide
mass of 3439.6, an increase of 112 over the oligonucleotide with
no modification at C34. Collision-induced dissociation tandem
mass spectrometry (CID-MS/MS) was attempted on this oligonu-
cleotide, but minimal sequence information could be obtained
likely due to the relatively large size of this RNase T1 digestion
product and the lability of the glycosidic bond involving the mod-
ified C34 (see below).
To obtain a shorter oligonucleotide more amenable to MS/MS,
a combination of RNase A and BAP was used to digest tRNAIle2 .
The sequence of the RNase A and BAP digestion product
of tRNAIle2 that covers the anticodon is the trinucleoside
diphosphate 5′-C*pApU-3′. Based on elution time and m∕z
values, several oligonucleotides were detected in the total ion
chromatograms (TIC) of the RNase A/BAP digest (Fig. 3A).
Each of these was sequenced and all except one,m∕z 989.3, could
be mapped onto the tRNAIle2 sequence. The selected ion chroma-
togram (SIC) of the oligonucleotide at m∕z 989.3 is shown in
Fig. 3B, and the corresponding mass spectrum of the ions eluting
at 4.5 min is shown in Fig. 3C. The mass spectrum shows that this
oligonucleotide elutes with GpC (m∕z 587.3) and ApGþpU
(m∕z 958.3), which are derived from nucleotides 49–50 and
14–16, respectively, of tRNAIle2 .
Because the difference in mass between the oligonucleotide at
m∕z 989.3 and the unmodified CpApU is 112 u and because there
are no unmodified nucleotide base compositions that match
990.3 u (989.3þHþ) nor any one known modification mass of
112 u, this oligonucleotide is most likely C*pApU. This assign-
ment is confirmed by MS/MS of m∕z 989.3 (Fig. 3D). The major
fragment ion is the loss of 223 (cytosineþ 112), indicating once
again the lability of the glycosidic bond and being consistent with
the finding above (Fig. 1C) that C* contains at least one positive
charge. The fragment ions at m∕z 572.1, 652.1, and 744.9 corre-
spond to cleavages of the C*pA phosphodiester bond, yielding y2
and w2 fragment ions, and the ApU phosphodiester bond, yield-
ing a d2-H2O fragment ion, respectively (Fig. S2) (22). Together,
these data establish the sequence of the trinucleotide as
½Cþ 112pApU. Thus, both RNase T1 mapping and RNase A/
BAP mapping and sequencing confirm that C34 is modified in
tRNAIle2 , with a net modification mass of 112 u. A modified
nucleoside of mass 355 (cytidineþ 112) was, therefore, used as
a search criterion during subsequent LC-MS/MS analysis of total
nucleosides derived from tRNAIle2 .
Modified Nucleosides Present in H. marismortui tRNAIle2 . The purified
tRNAIle2 was digested completely to nucleosides and analyzed by
LC-UV-MS (Fig. S3). All of the expected modified nucleosides in
tRNAIle2 were detected. The presence of 2′-deoxyribo-nucleosides
(dG, dA) indicates minor contamination with DNA oligonucleo-
tide used for the purification of the tRNA. SICs for the molecular
ion, m∕z 356 (MHþ), and the base ion, m∕z 224 (BHþ2 ), were
obtained demonstrating that a nucleoside of the expected mass
(from the RNase mapping and sequencing data) was present
in this sample (Fig. 4A and 4B). The mass difference of 132 u
between the molecular ion and the base ion is consistent with
location of the unknown modification on the base and not on
the ribose of the nucleoside. The mass spectrum from the SIC
is shown in Fig. 4C. The unknown modified cytidine C* coelutes
with the leading edge of archaeosine (m∕z 325.2).
Fig. 3. LC-MS/MS analysis of oligonucleotides present in RNase A/BAP
digests of H. marismortui tRNAIle2 . (A) TIC of RNase A/BAP digestion of
H. marismortui tRNAIle2 . (B) SIC of the anticodon-derived trinucleoside diphos-
phate 5′-C*pApU-3′ atm∕z 989.3. (C) Mass spectrum of oligonucleotides elut-
ing at 4.5 min. (D) MS/MS analysis of the trinucleoside diphosphate at m∕z
989.3 (22).
Fig. 2. Ribosome binding of H. marismortui tRNAIle1 and tRNA
Ile
2 . Template-
dependent binding of purified 3H-Ile-tRNAIle1 (A) and
3H-Ile-tRNAIle2 (B) to
ribosomes isolated from H. marismortui. Oligonucleotides used were
AUGAUG (▵), AUGAUA (□) and AUGAUC (○).
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Identification of C* as Agmatidine. Accurate mass analysis of the
protonated modified cytidine yielded an elemental composition
of C14H26N7O4 (measured 356.2038, expected 356.2040, error
0.6 ppm). Accurate mass analysis of the protonated modified base
yielded an elemental composition of C9H18N7 (measured
224.1617, expected 224.1618, error 0.4 ppm). The difference in
elemental composition of the nucleoside and base is consistent
with the absence of the C2-oxo group in this modified cytidine.
Accurate mass analysis of the CID-MS/MS fragments of the base
ion (Fig. 5A) yielded elemental compositions consistent with the
loss of NH3 (m∕z 207.1352) and CH5N3 (m∕z 165.1135) from the
modified cytidine.
The absence of the C2-oxo group, the relatively high nitrogen
content, and the fragmentation pattern suggested that the
modification was attachment of agmatine to the C2 of cytidine.
To confirm that loss of ammonia and a guanidino group are con-
sistent with the presence of agmatine (23), a solution of agmatine
was electrosprayed and subjected to MS/MS (Fig. 5B). The major
fragment ions were indeed loss of NH3 and CH5N3. Thus, taken
together, these data support the structure of C* as shown in Fig. 6.
Similar to lysidine, at neutral pH, agmatidine has the potential of
forming several tautomeric structures, three of which are shown
in Fig. 6.
The mass spectral data by themselves do not rule out an alter-
nate structure for agmatidine in which the C2 oxygen of cytidine
is replaced by hydrogen and agmatine is attached to the C5 or C6.
However, this is most unlikely for several reasons: (i) such a mod-
ified nucleoside would make tRNAIle2 base pair with AUG instead
of AUA (Fig. 2); (ii) the tRNAIle2 would be aminoacylated with
methionine instead of isoleucine (8, 9); (iii) it would not explain
the block in reverse transcriptase reaction by agmatidine (9); and
(iv) it would require, in addition to a reductase to reduce the C2
oxygen, the biochemically difficult linkage of C5 or C6 of cytidine
to the amino group of agmatine.
Agmatidine Is also Present in tRNAIle2 fromM. maripaludis and in Total
tRNA from S. solfataricus. The LC/MS analysis of nucleosides from
digests of partially purified tRNAIle2 from M. maripaludis and to-
tal tRNA from S. solfataricus (Fig. S4) shows that agmatidine is
also present in tRNAs from these archaeal organisms. Identifica-
tion of agmatidine was confirmed by the SICs and mass spectral
data. Thus, agmatidine is present in the AUA decoding tRNAIle2
of euryarchaea and crenarchaea.
Discussion
A clear conclusion of the work described in here is that archaea
and bacteria use very similar strategies to read the isoleucine
codon AUA without also reading the methionine codon AUG.
Agmatidine (abbreviation Cþ), identified here to be in the antic-
odon wobble position of the AUA decoding archaeal tRNAIle2 , is
in many respects similar to lysidine found in the corresponding
tRNA of bacteria. In both cases, the C2-oxo group of cytidine
is replaced by a long side chain derived from either lysine, an
amino acid, or by agmatine, a decarboxylated amino acid. The
only difference is that in lysidine, the linkage involves the side
Fig. 4. Mass spectral analysis of the modified cytidine C. Purified H. marismortui tRNAIle2 was digested to nucleosides and analyzed by LC-UV-MS (for complete
analysis see Fig. S3). Selected ion chromatograms of (A) the molecular ion at m∕z 356 (MHþ) and (B) the base ion at m∕z 224 (BHþ2 ). (C) Mass spectrum of the
modified cytidine C*; C* coelutes with the leading edge of archaeosine.
Fig. 5. Identification of the modified cytidine C*. (A) Accurate mass analysis of CID-MS/MS fragments of the base ion of C* (measuredm∕z 224.1617; expected
m∕z 224.1618). m∕z 207.1352 and m∕z 165.1135 are consistent with the loss of NH3 and CH5N3, respectively, from the base ion of C*. (B) MS fragmentation
pattern of an agmatine standard. m∕z 114.1 and m∕z 72.1 are consistent with the loss of NH3 and CH5N3, respectively, from agmatine.








chain amino group of lysine, whereas in agmatidine, it involves
the former α-amino group of arginine and not the guanidino
side chain. It is striking that archaea and bacteria use basically
similar, although different, types of base modification to generate
a cytidine derivative that can base pair only with A.
The archaeal translation apparatus is known to be a mosaic of
bacterial and eukaryotic features (24–26). Archaeal mRNAs are
bacterial-like in lacking the 5′-terminal cap and 3′-terminal PolyA
sequences and in using Shine–Dalgarno-like sequences and lead-
erless mRNAs for translation initiation. However, the archaeal
translation initiation factors, of which six have been identified,
are a subset of eukaryotic initiation factors (27, 28). In addition,
translation elongation and termination in archaea and eukaryotes
are similar based on patterns of antibiotic sensitivity of the
archaeal translation system (29) and on the biochemical and
genomic analysis of translation elongation and termination
factors, for example, the presence of diphthamide, a modified
histidine, in the elongation factor a/eEF2 (30), the presence of
hypusine, a critical modified lysine, in the elongation factor
a/eIF5A (31), and the presence of a single Class I transcription
termination factor a/eRF1, which reads all three stop codons
instead of two termination factors (RF1 and RF2) in bacteria.
In view of these substantial similarities between archaea and
eukaryotes, our finding that archaea use a strategy for translation
of the AUA codon that is similar to that used by bacteria but dif-
ferent from that used by eukaryotes is quite surprising.
As for lysidine, the identification of agmatidine in the AUA
specific archaeal tRNAIle2 raises the question of how agmatidine
base pairs specifically with A on the ribosome. Agmatidine has
the potential for forming several tautomeric structures (Fig. 6),
and it is not known which tautomeric form is present in the tRNA
and whether this form undergoes changes in the context of the
ribosome. Detailed structural studies will be necessary to under-
stand the mechanism of specific recognition of the AUA codon by
the corresponding archaeal and bacterial tRNAIles.
The identification of agmatidine in tRNAIle2 fromH. marismor-
tui andM. maripaludis and in total tRNA from S. solfataricus sug-
gests that agmatidine is present in the AUA decoding tRNAIle2 of
euryarchaea and crenarchaea. This conclusion is supported by the
finding that all sixty-six of the euryarchaeal and crenarchaeal
genomes sequenced have only one tRNA with the anticodon
GAU annotated as an isoleucine tRNA. This tRNA can read
the isoleucine codons AUU and AUC but not AUA. Interestingly,
all sixty-six of these archaeal genomes also contain at least three
tRNAs with the anticodon CAU, which are annotated as methio-
nine tRNA (KEGG database; http://www.genome.jp/kegg/).
As shown by us here and elsewhere for the H. marismortui
tRNAIle2 (9) and for theM. maripaludis tRNA
Ile
2 , one of these pu-
tative methionine tRNAs is actually the AUA decoding isoleucine
tRNA. Therefore, it is likely that in the rest of euryarchaea and
crenarchaea also, the anticodon wobble nucleoside C of one of
the putative methionine tRNAs is modified to agmatidine to gen-
erate a tRNA, which is aminoacylated with isoleucine and which
reads the isoleucine codon AUA. It is interesting to note that in
contrast to H. marismortui, in which AUA is a very rare codon
(3.6∕1000 codons), in S. solfataricus it is the most frequent codon
(49.4∕1000 codons) (http://www.kazusa.or.jp/codon/). Thus, the
use of agmatidine in tRNAIle2 does not depend on the frequency
of utilization of the AUA codon in mRNA.
In contrast to euryarchaea and crenarchaea, in the only avail-
able genome sequences of a nanoarchaeum and a korarchaeum,
two tRNA genes are annotated as coding for isoleucine tRNAs
(32–34). One of them would have the anticodon GAU, whereas
the other one would have the anticodon UAU, which is likely
modified to ΨAΨ as in eukaryotic tRNAIle2 (8). This latter tRNA
would have the potential for reading the AUA codon although
how it would be prevented from also reading the methionine co-
don AUG is unknown. The genome sequences could suggest that
nanoarchaea and korarchaea use a eukaryote-like strategy to
read the isoleucine codon AUA. However, before reaching this
conclusion, it is important to sequence additional nanoarchaeal
and korarchaeal genomes to determine whether other isolates of
nanoarchaea and korarchaea also have a tRNAIle2 with the antic-
odon UAU (possibly ΨAΨ) or have C*AU (C ¼ agmatidine) as
in euryarchaea and crenarchaea.
The very similar structures of agmatidine and lysidine suggest a
simple pathway for biosynthesis of agmatidine, similar to that of
lysidine, involving activation of the C2 of cytidine by adenylation
followed by nucleophilic attack on the activated C2 by the pri-
mary amino group of agmatine (35, 36). Agmatine is derived
by decarboxylation of arginine and occurs naturally as one of
the intermediates in polyamine biosynthesis. In the thermophilic
euryarchaeon T. kodakaraensis, agmatine is essential for poly-
amine biosynthesis (12). Agmatine is also an important neuronal
modulator, which binds to various receptors such as the α2-
adrenergic receptor, NMDA receptors, etc. (10, 11). It has
also been suggested to be a neurotransmitter, although that
remains to be proven (37). In view of the critical role of
agmatidine in archaeal AUA decoding tRNAIle2 function, the
potential involvement of agmatine in agmatidine biosynthesis
suggests that agmatine may also be essential in euryarchaea
and crenarchaea for the reading of the genetic code.
Although agmatidine and lysidine are very similar modified
nucleosides, both derived from cytidine, in spite of extensive
bioinformatics searches, no homolog of TilS, the enzyme respon-
sible for biosynthesis of lysidine in bacteria, has been detected in
archaea (38). This raises the interesting question of how similar
the enzyme responsible for biosynthesis of agmatidine is to TilS
and whether the two enzymes are products of convergent
evolution. Clearly, an analysis of the evolutionary history of these
enzymes would be of much interest.
Materials and Methods
Purification of tRNAIle1 and tRNA
Ile
2 from H. marismortui. H. marismortui ATCC
43,049 was kindly provided by Peter Moore (Yale University). General manip-
ulations ofH. marismortuiwere performed according to standard procedures
(39). Cells were grown at 37 ºC, harvested in late-log phase, and crude RNA
was isolated by acid guanidinium thiocyanate-phenol-chloroform extraction
(40). Ribosomal RNA was removed by precipitation with 1 M NaCl yielding
total tRNA. The yield of total tRNA was approximately 1; 000 A260 units from
a 15 L-culture. Purification of tRNAs was carried out essentially as described
by Suzuki and Suzuki (41). Details are given in SI Text.
Binding of 3H-Ile-tRNAIle to Ribosomes. H. marismortui ribosomes were
isolated essentially as described (42) with slight modifications. Pelleted
cells from a 2 L-culture were suspended in 10 mM Tris-HCl pH 7.5,
100 mMMgðOAcÞ2 and 3.4 M KCl (buffer 1) and lysed by French Press
(Constant Cell Disruption System), and the lysate was cleared of cell debris
by centrifugation first at 27; 000 × g for 15 min and then at 65; 000 × g for
Fig. 6. Comparison of agmatidine present in the anticodon wobble position
of the archaeal AUA-decoding tRNAIle2 to lysidine present in the correspond-
ing bacterial tRNA. Possible tautomeric structures of protonated agmatidine
and lysidine are shown. Tautomers 1 and 2 could base pair with A.
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15 min. Ribosomes were then pelleted at 255; 000 × g for 4 hr and suspended
in buffer 1. The ribosome suspension was divided into aliquots, quick frozen,
and stored at −80 ¨C. Ribosome binding was adapted from Bayley and
Griffiths (43) with modifications. Details are given in SI Text.
Digestion of tRNA to Nucleosides. Purified H. marismortui tRNAIle2 (0.2 A260
unit), purified M. maripaludis tRNAIle2 (0.6 A260 unit), H. marismortui total
tRNA (0.6 A260 unit) and S. solfataricus total tRNA (1.0 A260 unit) were
digested to nucleosides using nuclease P1 (Sigma), snake venom phospho-
diesterase I (Worthington Biochemical Corporation) and antarctic phospha-
tase (New England Biolabs) as described by Crain (44).
Digestion of tRNAIle2 with Nucleases and LC-MS and LC-MS/MS. LC-MS to map
RNase A and T1 digestion products onto the tRNA, LC-MS/MS to sequence the
oligonucleotides in RNase A digests, and accurate mass LC-MS and LC-MS/MS
analysis of total nucleoside digests of the tRNAIle2 were carried out as
described (45) with modifications. Details are given in SI Text.
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